Mytishchi, Russia

Sergej Ossipov

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergej Ossipov. Retrieved from https://idiyas.com/inventor/sergej-ossipov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Spotlight on Inventor Sergej Ossipov

Introduction:

Sergej Ossipov, a talented inventor hailing from Mytischi, Russia, is making waves in the world of innovation with his groundbreaking work in the field of pharmaceuticals.

Latest Patents:

With an impressive portfolio of one patent to his name, Sergej's patent titled "Bis(trifluoromethyl)hydantoins as intermediates for pharmaceutically active ingredients" showcases his expertise and ingenuity in developing essential components for pharmaceutical products.

Career Highlights:

Sergej Ossipov is a valued member of the esteemed Aventis Pharma Deutschland, GmbH, where he applies his knowledge and skills to drive forward advancements in the pharmaceutical industry. His dedication to research and development is evident in the quality of his patent.

Collaborations:

In his professional journey, Sergej has had the privilege of collaborating with accomplished individuals in the field, including Volkmar Wehner and Hans Ulrich Stilz. Together, they have worked towards achieving innovative solutions and pushing the boundaries of pharmaceutical science.

Conclusion:

Inventor Sergej Ossipov's contributions to the field of pharmaceuticals stand as a testament to his passion for innovation and his commitment to improving global healthcare. With a bright future ahead, Sergej continues to inspire with his groundbreaking inventions and dedication to creating a better world through his work.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…